Institutional investors now have $818 million stake in Radius Health, Inc. (RDUS)

Radius Health, Inc. (NASDAQ:RDUS) marched up 28.33% compared to a 52-week low price of $12.81. The shares were last seen trading -2.95% lower, taking the closing price at $16.44 on 01/11/2019. At recent session, the prices were hovering between $16.28 and $17.15. This company shares are 118.13% off its target price of $35.86 and the current market capitalization stands at $771.36M. The recent change has given its price a 2.46% lead over SMA 50 and -60.06% deficit over its 52-week high. The stock witnessed 0.74% gains, -10.85% declines and -46.13% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found RDUS’s volatility during a week at 6.01% and during a month it has been found around 7.06%.

Radius Health, Inc. (RDUS) Top Holders

Institutional investors currently hold around $818 million or 0% in RDUS stock. Look at its top three institutional owners. Bb Biotech Ag owns $108.34 million in Radius Health, Inc., which represents roughly 14.05% of the company’s market cap and approximately 13.24% of the institutional ownership. Similar statistics are true for the second largest owner, State Street Corp, which owns 3,656,777 shares of the stock are valued at $60.12 million. The third largest holder is Healthcor Management, L.P., which currently holds $58.93 million worth of this stock and that ownership represents nearly 7.64% of its market capitalization.

Radius Health, Inc. 13F Filings

At the end of September reporting period, 82 institutional holders increased their position in Radius Health, Inc. (NASDAQ:RDUS) by some 11,469,408 shares, 47 decreased positions by 14,517,512 and 24 held positions by 23,797,955. That puts total institutional holdings at 49,784,875 shares, according to SEC filings. The stock grabbed 25 new institutional investments totaling 1,695,464 shares while 17 institutional investors sold out their entire positions totaling 6,911,015 shares.

Radius Health, Inc. (NASDAQ:RDUS) Insider Trades

Multiple company employees have indulged in significant insider trading. Radius Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Biotech Growth N V has acquired 60,000 shares of Radius Health, Inc. (RDUS) in trading session dated Dec. 20, 2018. These shares are worth $868,800 and were traded at $14.48 each. The SEC filing shows that Kelly Joseph Francis performed a purchase of 3,000 shares. The Sr. VP of Sales and Marketing added these shares by way of transaction on Dec. 17, 2018. The company’s shares were assimilated at $15.71 per share worth to an investment of some $47,130 on account of Kelly Joseph Francis.

10% Owner, Biotech Growth N V, purchased 60,000 common shares of Radius Health, Inc. (RDUS) in the open market. In a transaction dated Dec. 14, 2018, the shares were bought at an average price of $15.64, giving away a sum of $938,400. After this purchase, 6,650,276 common shares of RDUS are directly owned by the insider, with total stake valued at $109,330,537.

In the transaction dated Aug. 20, 2018, the great number of shares acquired came courtesy the 10% Owner; Biotech Growth N V added a total of 60,000 shares at an average price of $19.65, amounting to approximately $1,179,000. The insider now directly owns 6,590,276 shares worth $108,344,137.

Radius Health, Inc. (RDUS) Analyst Guide

Several analysts have released their opinion on Radius Health, Inc. (NASDAQ:RDUS), with 2 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.25 average brokerage recommendation.